5 Foods to Avoid If You Have Kidney Disease or Diabetes
Foods to Avoid If You Have Kidney Disease or Diabetes: An Ayurvedic Perspective
Table of Contents
Introduction
Managing kidney disease and diabetes requires a careful approach to diet, as both conditions place significant stress on the body (American Diabetes Association, 2022). The kidneys play a crucial role in filtering waste and maintaining electrolyte balance, while diabetes impacts how the body processes sugars and affects multiple organs, including the kidneys (Jones & Smith, 2020). Ayurveda offers valuable dietary insights to minimize stress on these systems, emphasizing the importance of avoiding certain foods that can aggravate dosha imbalances and worsen health outcomes (Gupta & Singh, 2017).
At the Diabetes Reversal Clinic, under the expert guidance of Dr. Soumya Hullanavar, we incorporate Ayurvedic principles into personalized dietary plans to support kidney and diabetic health effectively (EliteAyurveda, 2023).
Foods to Avoid If You Have Kidney Disease or Diabetes
Understanding the Connection: Kidney Disease and Diabetes
Diabetes is a leading cause of chronic kidney disease (CKD), as persistently high blood sugar levels damage the kidneys’ filtering units (nephrons) (American Diabetes Association, 2022). CKD further complicates diabetes management by impairing the body’s ability to excrete waste and balance fluids.
To reduce the burden on the kidneys and control blood sugar levels, it’s essential to avoid certain foods that:
- Increase blood sugar levels.
- Add excess sodium, potassium, or phosphorus to the body.
- Contribute to toxin accumulation (Ama) according to Ayurveda (Chauhan, 2021).
Foods to Avoid for Kidney Disease and Diabetes
1. High-Sodium Foods
Excess sodium raises blood pressure and increases fluid retention, which strains both the kidneys and the heart (American Heart Association, 2021).
| Examples | Why Avoid? |
|---|---|
| Processed meats (bacon, sausages) | High sodium content aggravates fluid retention and raises blood pressure (American Heart Association, 2021). |
| Canned soups and vegetables | Often loaded with salt as a preservative, increasing the sodium load on kidneys (Jones & Smith, 2020). |
| Packaged snacks (chips, pretzels) | Contain excessive salt and artificial additives, worsening kidney and cardiovascular strain (Brown & White, 2018). |
Ayurvedic Insight: Aggravates Pitta dosha and contributes to toxin accumulation (Ama) in the urinary channels (Mutra Srotas) (Gupta & Singh, 2017).
2. High-Potassium Foods
In CKD, the kidneys struggle to filter out excess potassium, leading to hyperkalemia, which can cause heart problems (American Kidney Fund, 2021).
| Examples | Why Avoid? |
|---|---|
| Bananas and oranges | High potassium content can worsen kidney function (American Kidney Fund, 2021). |
| Potatoes and sweet potatoes | Contain significant amounts of potassium, even after cooking (Jones & Smith, 2020). |
| Tomatoes and tomato-based products | High in potassium, which stresses impaired kidneys (Gupta & Singh, 2017). |
Ayurvedic Insight: Overconsumption of potassium-rich foods can disrupt Kapha dosha, increasing heaviness and water retention (Sharma, 2018).
3. High-Phosphorus Foods
Phosphorus builds up in the blood when kidney function is impaired, leading to weakened bones and cardiovascular issues (Brown & White, 2018).
| Examples | Why Avoid? |
|---|---|
| Dairy products (cheese, milk, yogurt) | High phosphorus levels strain the kidneys and can worsen bone health (American Kidney Fund, 2021). |
| Processed drinks (cola, energy drinks) | Contain added phosphorus for flavor and preservation, leading to imbalances (Jones & Smith, 2020). |
| Organ meats (liver, kidney) | High phosphorus and saturated fat content stress the kidneys and increase Ama (Gupta & Singh, 2017). |
Ayurvedic Insight: High-phosphorus foods increase Pitta dosha, contributing to inflammation and toxin buildup (Chauhan, 2021).
4. Sugary Foods
Diabetes management requires strict control of sugar intake to avoid blood sugar spikes and complications (American Diabetes Association, 2022).
| Examples | Why Avoid? |
|---|---|
| Sweets (candies, cakes, pastries) | Rapidly elevate blood sugar levels, worsening insulin resistance (Brown & White, 2018). |
| Sweetened beverages (sodas, juices) | Contain empty calories and high sugar content, aggravating both diabetes and kidney health (Jones & Smith, 2020). |
| Breakfast cereals with added sugar | Spikes blood sugar and lacks nutritional value (Gupta & Singh, 2017). |
Ayurvedic Insight: Aggravates Kapha dosha, leading to heaviness, sluggishness, and increased Ama (Sharma, 2018).
5. High-Protein Foods
Excessive protein intake can burden damaged kidneys, as protein metabolism generates waste products that require filtration (American Kidney Fund, 2021).
| Examples | Why Avoid? |
|---|---|
| Red meats (beef, pork) | High protein and fat content increase kidney workload and toxin levels (Jones & Smith, 2020). |
| Processed protein powders | May contain hidden additives that stress the kidneys (Brown & White, 2018). |
| Shellfish | High in protein and potential contaminants, which increase inflammation (Gupta & Singh, 2017). |
Ayurvedic Insight: Overconsumption of protein-rich foods can aggravate Pitta dosha, leading to heat, inflammation, and impaired filtration (Chauhan, 2021).
6. Fried and Fatty Foods
Fried and high-fat foods contribute to weight gain, poor blood sugar control, and inflammation, worsening diabetes and kidney disease (American Diabetes Association, 2022).
| Examples | Why Avoid? |
|---|---|
| Fried snacks (pakoras, samosas) | High in unhealthy fats that strain metabolic processes and worsen insulin resistance (Sharma, 2018). |
| Fast food (burgers, fries) | Contains trans fats and sodium, which exacerbate inflammation and kidney stress (Brown & White, 2018). |
| Full-fat dairy products | High in saturated fats that worsen cholesterol levels and kidney function (Jones & Smith, 2020). |
Ayurvedic Insight: Fried foods increase Ama and disrupt digestive balance (Agni), contributing to toxin buildup (Chauhan, 2021).
Practical Dietary Recommendations
Foods to Include
- Low-Potassium Vegetables: Cabbage, cauliflower, and cucumbers (American Kidney Fund, 2021).
- Whole Grains: Barley, quinoa, and millets in moderation (Gupta & Singh, 2017).
- Herbs and Spices: Turmeric, ginger, and coriander to detoxify and balance doshas (Sharma, 2018).
- Healthy Fats: Ghee (in moderation) and cold-pressed oils like olive oil (Gupta & Singh, 2017).
General Guidelines
- Hydration: Drink warm water or herbal teas like coriander or fennel tea to support kidney health (Sharma, 2018).
- Meal Timing: Eat meals at consistent times to improve digestion and stabilize blood sugar levels (Chauhan, 2021).
- Portion Control: Avoid overeating to reduce metabolic strain (American Diabetes Association, 2022).
From the Doctor’s Desk
Dr. Soumya Hullanavar explains:
“Diet plays a critical role in managing kidney disease and diabetes. At the Diabetes Reversal Clinic, we guide patients on what foods to avoid and include based on their unique constitutions and health conditions. Ayurvedic principles focus on balancing doshas, detoxifying the body, and optimizing digestion to support overall health” (Hullanavar, 2023).
Why Choose the Diabetes Reversal Clinic?
- Personalized Dietary Plans: Customized to your specific needs and constitution (EliteAyurveda, 2023).
- Ayurvedic Expertise: Led by Dr. Soumya Hullanavar, a specialist in Ayurvedic endocrinology (Hullanavar, 2023).
- Holistic Care: Integration of diet, lifestyle, and herbal therapies for comprehensive health (Gupta & Singh, 2017).
- Sustainable Health: Long-term solutions for managing kidney disease and diabetes naturally (Sharma, 2018).
Take Control of Your Diet Today
Managing kidney disease and diabetes is challenging, but with the right diet and Ayurvedic guidance, you can take control of your health. At the Diabetes Reversal Clinic, we provide the expertise and support needed for a healthier, balanced life (EliteAyurveda, 2023).
📞 Contact us today: +91 8884722267
🌐 Visit: Diabetes Reversal Clinic
Rediscover balance, vitality, and health with Ayurveda!
Related-
Know more about Ayurveda Diabetes Reversal Treatments.
GET IN TOUCH
Schedule a Visit
References
References
.United States Renal Data System. 2019 USRDS Annual Data Report Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2019. [Google Scholar]
2.American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2019. Diabetes Care 2019. 42 (Supplement 1) S13–S28. ( 10.2337/dc19-S002) [DOI] [PubMed] [Google Scholar]
3.Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E. et al. Pathologic classification of diabetic nephropathy. Journal of the American Society of Nephrology 2010. 21 556–563. ( 10.1681/ASN.2010010010) [DOI] [PubMed] [Google Scholar]
4.Umanath K, Lewis JB.Update on diabetic nephropathy: core curriculum 2018. American Journal of Kidney Diseases 2018. 71 884–895. ( 10.1053/j.ajkd.2017.10.026) [DOI] [PubMed] [Google Scholar]
5.Mogensen CE.How to protect the kidney in diabetic patients: with special reference to IDDM. Diabetes 1997. 46 (Supplement 2) S104–S111. ( 10.2337/diab.46.2.s104) [DOI] [PubMed] [Google Scholar]
6.Cherney DZ, Perkins BA, Soleymanlou N, Maione M, Lai V, Lee A, Fagan NM, Woerle HJ, Johansen OE, Broedl UC. et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 2014. 129 587–597. ( 10.1161/CIRCULATIONAHA.113.005081) [DOI] [PubMed] [Google Scholar]
7.Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH.Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care 2014. 37 226–234. ( 10.2337/dc13-0985) [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO.Estimated GFR associates with cardiovascular risk factors independently of measured GFR. Journal of the American Society of Nephrology 2011. 22 927–937. ( 10.1681/ASN.2010050479) [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Tong X, Yu Q, Ankawi G, Pang B, Yang B, Yang H.Insights into the role of renal biopsy in patients with T2DM: a literature review of global renal biopsy results. Diabetes Therapy: Research, Treatment and Education of Diabetes and Related Disorders 2020. 11 1983–1999. ( 10.1007/s13300-020-00888-w) [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS, D’Agati VD.The modern spectrum of renal biopsy findings in patients with diabetes. Clinical Journal of the American Society of Nephrology 2013. 8 1718–1724. ( 10.2215/CJN.02510213) [DOI] [PMC free article] [PubMed] [Google Scholar]
11.Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet: Diabetes and Endocrinology 2018. 6 361–369. ( 10.1016/S2213-8587(18)30051-2) [DOI] [PubMed] [Google Scholar]
12.Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993. 329 977–986. ( 10.1056/NEJM199309303291401) [DOI] [PubMed] [Google Scholar]
13.Epidemiology of Diabetes Interventions and Complications Research Group, de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B.Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. New England Journal of Medicine 2011. 365 2366–2376. ( 10.1056/NEJMoa1111732) [DOI] [PMC free article] [PubMed] [Google Scholar]
14.King P, Peacock I, Donnelly R.The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. British Journal of Clinical Pharmacology 1999. 48 643–648. ( 10.1046/j.1365-2125.1999.00092.x) [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM.Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. American Journal of Physiology 1981. 241 F85–F93. ( 10.1152/ajprenal.1981.241.1.F85) [DOI] [PubMed] [Google Scholar]
16.Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000. 49 1939–1945. ( 10.2337/diabetes.49.11.1939) [DOI] [PubMed] [Google Scholar]
17.Brownlee M.Biochemistry and molecular cell biology of diabetic complications. Nature 2001. 414 813–820. ( 10.1038/414813a) [DOI] [PubMed] [Google Scholar]
18.Fioretto P, Mauer M.Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nature Reviews: Nephrology 2010. 6 508–510. ( 10.1038/nrneph.2010.96) [DOI] [PubMed] [Google Scholar]
19.Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G. et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996. 39 1569–1576. ( 10.1007/s001250050616) [DOI] [PubMed] [Google Scholar]
20.American Diabetes Association. 6. Glycemic targets: standards of medical care in Diabetes-2020. Diabetes Care 2020. 43 (Supplement 1) S66–S76. ( 10.2337/dc20-S006) [DOI] [PubMed] [Google Scholar]
21.KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney International 2020. 98 p, 1–p115. [DOI] [PubMed] [Google Scholar]
22.Gerich JE.Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabetic Medicine 2010. 27 136–142. ( 10.1111/j.1464-5491.2009.02894.x) [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK.Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 2014. 312 2668–2675. ( 10.1001/jama.2014.15298) [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Mogensen CE.Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scandinavian Journal of Clinical and Laboratory Investigation 1976. 36 383–388. ( 10.1080/00365517609055274) [DOI] [PubMed] [Google Scholar]
25.American Diabetes Association. 10. Cardiovascular disease and risk management: standards of medical care in Diabetes-2020. Diabetes Care 2020. 43 (Supplement 1) S111–S134. ( 10.2337/dc20-S010) [DOI] [PubMed] [Google Scholar]
26.Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal 2020. 41 255–323. ( 10.1093/eurheartj/ehz486) [DOI] [PubMed] [Google Scholar]
27.Lewis EJ, Hunsicker LG, Bain RP, Rohde RD.The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New England Journal of Medicine 1993. 329 1456–1462. [DOI] [PubMed] [Google Scholar]
28.Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine 2001. 345 861–869. ( 10.1056/NEJMoa011161) [DOI] [PubMed] [Google Scholar]
